Profile picture

Doctor Ambarish Pandey

University of Texas Southwestern Medical Center, Dallas (United States of America)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

Biomarker-guided approach for heart failure prevention in patients with diabetes
Presentation
Biomarker-guided approach for heart failure prevention in patients with diabetes
Mortality-based clustering reveals distinct subgroups in heart failure with preserved ejection fraction
Presentation
Mortality-based clustering reveals distinct subgroups in heart failure with preserved ejection fraction
Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: a post-hoc analysis of the CLOROTIC Trial
Presentation
Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: a post-hoc analysis of the CLOROTIC Trial
Implementing an AI-ECG based algorithm to screen for left ventricular dysfunction in Kenya: a prospective cohort study
Presentation
Implementing an AI-ECG based algorithm to screen for left ventricular dysfunction in Kenya: a prospective cohort study
Performance of an automated echocardiographic artificial intelligence model.  to detect subclinical heart failure with preserved ejection fraction (HFpEF) in community-dwelling older adults
Presentation
Performance of an automated echocardiographic artificial intelligence model. to detect subclinical heart failure with preserved ejection fraction (HFpEF) in community-dwelling older adults
Association of baseline and longitudinal changes in cardiometabolic health with risk of heart failure among adults with type 2 diabetes: an analysis from the Look AHEAD trial
Presentation
Association of baseline and longitudinal changes in cardiometabolic health with risk of heart failure among adults with type 2 diabetes: an analysis from the Look AHEAD trial
Efficacy of ertugliflozin on hospitalisation for heart failure across the distribution of pre-trial ejection fraction: post hoc analyses of the VERTIS CV trial
Presentation
Efficacy of ertugliflozin on hospitalisation for heart failure across the distribution of pre-trial ejection fraction: post hoc analyses of the VERTIS CV trial

ESC 365 is supported by